 | • レポートコード：MRC2012A5216 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腎臓（腎）線維症の世界市場を広く調査・分析し、今後の市場展望をまとめております。腎臓（腎）線維症の種類別市場規模（アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤）、用途別市場規模（研究センター、病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、BioLine Rx Ltd、InterMune、Pfizer、ProMetic Life-Sciences Inc.、Roche、La Jolla Pharmaceutical Company、Galectin Therapeutics、Genzyme Corporation、 ・地域別グローバル市場分析 2015年-2020年 ・腎臓（腎）線維症の北米市場（アメリカ、カナダ、メキシコ） ・腎臓（腎）線維症のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腎臓（腎）線維症のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腎臓（腎）線維症の南米市場（ブラジル、アルゼンチン） ・腎臓（腎）線維症の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤 ・用途別分析：研究センター、病院、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Kidney (Renal) Fibrosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Kidney (Renal) Fibrosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Kidney (Renal) Fibrosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Kidney (Renal) Fibrosis market has been segmented into
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
By Application, Kidney (Renal) Fibrosis has been segmented into:
Research Center
Hospital
Clinic
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Kidney (Renal) Fibrosis market presented in the report. This section sheds light on the sales growth of different regional and country-level Kidney (Renal) Fibrosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Kidney (Renal) Fibrosis market.
The report offers in-depth assessment of the growth and other aspects of the Kidney (Renal) Fibrosis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Kidney (Renal) Fibrosis Market Share Analysis
Kidney (Renal) Fibrosis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Kidney (Renal) Fibrosis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Kidney (Renal) Fibrosis sales, revenue and market share for each player covered in this report.
The major players covered in Kidney (Renal) Fibrosis are:
Merck
BioLine Rx Ltd
InterMune
Pfizer
ProMetic Life-Sciences Inc.
Roche
La Jolla Pharmaceutical Company
Galectin Therapeutics
Genzyme Corporation
Among other players domestic and global, Kidney (Renal) Fibrosis market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Kidney (Renal) Fibrosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney (Renal) Fibrosis, with price, sales, revenue and global market share of Kidney (Renal) Fibrosis in 2018 and 2019.
Chapter 3, the Kidney (Renal) Fibrosis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney (Renal) Fibrosis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Kidney (Renal) Fibrosis market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Kidney (Renal) Fibrosis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Kidney (Renal) Fibrosis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney (Renal) Fibrosis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Angiotensin Converting enzyme (ACE) Inhibitors
1.2.3 Pirfenidone
1.2.4 Renin Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Vasopeptidase Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney (Renal) Fibrosis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Overview of Global Kidney (Renal) Fibrosis Market
1.4.1 Global Kidney (Renal) Fibrosis Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioLine Rx Ltd
2.2.1 BioLine Rx Ltd Details
2.2.2 BioLine Rx Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioLine Rx Ltd SWOT Analysis
2.2.4 BioLine Rx Ltd Product and Services
2.2.5 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 InterMune
2.3.1 InterMune Details
2.3.2 InterMune Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 InterMune SWOT Analysis
2.3.4 InterMune Product and Services
2.3.5 InterMune Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 ProMetic Life-Sciences Inc.
2.5.1 ProMetic Life-Sciences Inc. Details
2.5.2 ProMetic Life-Sciences Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ProMetic Life-Sciences Inc. SWOT Analysis
2.5.4 ProMetic Life-Sciences Inc. Product and Services
2.5.5 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 La Jolla Pharmaceutical Company
2.7.1 La Jolla Pharmaceutical Company Details
2.7.2 La Jolla Pharmaceutical Company Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 La Jolla Pharmaceutical Company SWOT Analysis
2.7.4 La Jolla Pharmaceutical Company Product and Services
2.7.5 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Galectin Therapeutics
2.8.1 Galectin Therapeutics Details
2.8.2 Galectin Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Galectin Therapeutics SWOT Analysis
2.8.4 Galectin Therapeutics Product and Services
2.8.5 Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genzyme Corporation
2.9.1 Genzyme Corporation Details
2.9.2 Genzyme Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genzyme Corporation SWOT Analysis
2.9.4 Genzyme Corporation Product and Services
2.9.5 Genzyme Corporation Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Kidney (Renal) Fibrosis Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Kidney (Renal) Fibrosis Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Kidney (Renal) Fibrosis Manufacturer Market Share in 2019
3.3.2 Top 6 Kidney (Renal) Fibrosis Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Kidney (Renal) Fibrosis Sales, Revenue and Market Share by Regions
4.1.1 Global Kidney (Renal) Fibrosis Sales and Market Share by Regions (2015-2020)
4.1.2 Global Kidney (Renal) Fibrosis Revenue and Market Share by Regions (2015-2020)
4.2 North America Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
4.3 Europe Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
4.5 South America Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Kidney (Renal) Fibrosis Sales, Revenue and Market Share by Country
5.1.1 North America Kidney (Renal) Fibrosis Sales and Market Share by Country (2015-2020)
5.1.2 North America Kidney (Renal) Fibrosis Revenue and Market Share by Country (2015-2020)
5.2 United States Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
5.3 Canada Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
5.4 Mexico Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Kidney (Renal) Fibrosis Sales, Revenue and Market Share by Country
6.1.1 Europe Kidney (Renal) Fibrosis Sales and Market Share by Country (2015-2020)
6.1.2 Europe Kidney (Renal) Fibrosis Revenue and Market Share by Country (2015-2020)
6.2 Germany Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
6.3 UK Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
6.4 France Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
6.5 Russia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
6.6 Italy Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Kidney (Renal) Fibrosis Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Kidney (Renal) Fibrosis Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Kidney (Renal) Fibrosis Revenue and Market Share by Regions (2015-2020)
7.2 China Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
7.3 Japan Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
7.4 Korea Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
7.5 India Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
7.7 Australia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Kidney (Renal) Fibrosis Sales, Revenue and Market Share by Country
8.1.1 South America Kidney (Renal) Fibrosis Sales and Market Share by Country (2015-2020)
8.1.2 South America Kidney (Renal) Fibrosis Revenue and Market Share by Country (2015-2020)
8.2 Brazil Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
8.3 Argentina Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Kidney (Renal) Fibrosis Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Kidney (Renal) Fibrosis Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Kidney (Renal) Fibrosis Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
9.3 Turkey Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
9.4 Egypt Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
9.5 South Africa Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Kidney (Renal) Fibrosis Sales and Market Share by Type (2015-2020)
10.2 Global Kidney (Renal) Fibrosis Revenue and Market Share by Type (2015-2020)
10.3 Global Kidney (Renal) Fibrosis Price by Type (2015-2020)
11 Global Kidney (Renal) Fibrosis Market Segment by Application
11.1 Global Kidney (Renal) Fibrosis Sales Market Share by Application (2015-2020)
11.2 Global Kidney (Renal) Fibrosis Revenue Market Share by Application (2015-2020)
11.3 Global Kidney (Renal) Fibrosis Price by Application (2015-2020)
12 Market Forecast
12.1 Global Kidney (Renal) Fibrosis Sales, Revenue and Growth Rate (2021-2025)
12.2 Kidney (Renal) Fibrosis Market Forecast by Regions (2021-2025)
12.2.1 North America Kidney (Renal) Fibrosis Market Forecast (2021-2025)
12.2.2 Europe Kidney (Renal) Fibrosis Market Forecast (2021-2025)
12.2.3 Asia-Pacific Kidney (Renal) Fibrosis Market Forecast (2021-2025)
12.2.4 South America Kidney (Renal) Fibrosis Market Forecast (2021-2025)
12.2.5 Middle East & Africa Kidney (Renal) Fibrosis Market Forecast (2021-2025)
12.3 Kidney (Renal) Fibrosis Market Forecast by Type (2021-2025)
12.3.1 Global Kidney (Renal) Fibrosis Sales Forecast by Type (2021-2025)
12.3.2 Global Kidney (Renal) Fibrosis Market Share Forecast by Type (2021-2025)
12.4 Kidney (Renal) Fibrosis Market Forecast by Application (2021-2025)
12.4.1 Global Kidney (Renal) Fibrosis Sales Forecast by Application (2021-2025)
12.4.2 Global Kidney (Renal) Fibrosis Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Kidney (Renal) Fibrosis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Kidney (Renal) Fibrosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Kidney (Renal) Fibrosis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Kidney (Renal) Fibrosis Major Business
Table 9. Merck Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Kidney (Renal) Fibrosis Product and Services
Table 12. Merck Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. BioLine Rx Ltd Basic Information, Manufacturing Base and Competitors
Table 14. BioLine Rx Ltd Kidney (Renal) Fibrosis Major Business
Table 15. BioLine Rx Ltd Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 16. BioLine Rx Ltd SWOT Analysis
Table 17. BioLine Rx Ltd Kidney (Renal) Fibrosis Product and Services
Table 18. BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. InterMune Basic Information, Manufacturing Base and Competitors
Table 20. InterMune Kidney (Renal) Fibrosis Major Business
Table 21. InterMune Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 22. InterMune SWOT Analysis
Table 23. InterMune Kidney (Renal) Fibrosis Product and Services
Table 24. InterMune Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Kidney (Renal) Fibrosis Major Business
Table 27. Pfizer Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Kidney (Renal) Fibrosis Product and Services
Table 30. Pfizer Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. ProMetic Life-Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table 32. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Major Business
Table 33. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 34. ProMetic Life-Sciences Inc. SWOT Analysis
Table 35. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product and Services
Table 36. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Roche Basic Information, Manufacturing Base and Competitors
Table 38. Roche Kidney (Renal) Fibrosis Major Business
Table 39. Roche Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 40. Roche SWOT Analysis
Table 41. Roche Kidney (Renal) Fibrosis Product and Services
Table 42. Roche Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 44. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Major Business
Table 45. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 46. La Jolla Pharmaceutical Company SWOT Analysis
Table 47. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product and Services
Table 48. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 50. Galectin Therapeutics Kidney (Renal) Fibrosis Major Business
Table 51. Galectin Therapeutics Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 52. Galectin Therapeutics SWOT Analysis
Table 53. Galectin Therapeutics Kidney (Renal) Fibrosis Product and Services
Table 54. Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Genzyme Corporation Kidney (Renal) Fibrosis Major Business
Table 57. Genzyme Corporation Kidney (Renal) Fibrosis Total Revenue (USD Million) (2017-2018)
Table 58. Genzyme Corporation SWOT Analysis
Table 59. Genzyme Corporation Kidney (Renal) Fibrosis Product and Services
Table 60. Genzyme Corporation Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Kidney (Renal) Fibrosis Sales by Manufacturer (2018-2019) (MT)
Table 62. Global Kidney (Renal) Fibrosis Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Kidney (Renal) Fibrosis Sales by Regions (2015-2020) (MT)
Table 64. Global Kidney (Renal) Fibrosis Sales Market Share by Regions (2015-2020)
Table 65. Global Kidney (Renal) Fibrosis Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Kidney (Renal) Fibrosis Sales by Countries (2015-2020) (MT)
Table 67. North America Kidney (Renal) Fibrosis Sales Market Share by Countries (2015-2020)
Table 68. North America Kidney (Renal) Fibrosis Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Kidney (Renal) Fibrosis Revenue Market Share by Countries (2015-2020)
Table 70. Europe Kidney (Renal) Fibrosis Sales by Countries (2015-2020) (MT)
Table 71. Europe Kidney (Renal) Fibrosis Sales Market Share by Countries (2015-2020)
Table 72. Europe Kidney (Renal) Fibrosis Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Kidney (Renal) Fibrosis Sales by Regions (2015-2020) (MT)
Table 74. Asia-Pacific Kidney (Renal) Fibrosis Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Kidney (Renal) Fibrosis Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Kidney (Renal) Fibrosis Sales by Countries (2015-2020) (MT)
Table 77. South America Kidney (Renal) Fibrosis Sales Market Share by Countries (2015-2020)
Table 78. South America Kidney (Renal) Fibrosis Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Kidney (Renal) Fibrosis Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Kidney (Renal) Fibrosis Sales by Countries (2015-2020) (MT)
Table 81. Middle East & Africa Kidney (Renal) Fibrosis Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Kidney (Renal) Fibrosis Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Kidney (Renal) Fibrosis Revenue Market Share by Countries (2015-2020)
Table 84. Global Kidney (Renal) Fibrosis Sales by Type (2015-2020) (MT)
Table 85. Global Kidney (Renal) Fibrosis Sales Share by Type (2015-2020)
Table 86. Global Kidney (Renal) Fibrosis Revenue by Type (2015-2020) (USD Million)
Table 87. Global Kidney (Renal) Fibrosis Revenue Share by Type (2015-2020)
Table 88. Global Kidney (Renal) Fibrosis Sales by Application (2015-2020) (MT)
Table 89. Global Kidney (Renal) Fibrosis Sales Share by Application (2015-2020)
Table 90. Global Kidney (Renal) Fibrosis Sales Forecast by Regions (2021-2025) (MT)
Table 91. Global Kidney (Renal) Fibrosis Market Share Forecast by Regions (2021-2025)
Table 92. Global Kidney (Renal) Fibrosis Sales Forecast by Type (2021-2025) (MT)
Table 93. Global Kidney (Renal) Fibrosis Market Share Forecast by Type (2021-2025)
Table 94. Global Kidney (Renal) Fibrosis Sales Forecast by Application (2021-2025)
Table 95. Global Kidney (Renal) Fibrosis Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Kidney (Renal) Fibrosis Picture
Figure 2. Global Sales Market Share of Kidney (Renal) Fibrosis by Type in 2019
Figure 3. Angiotensin Converting enzyme (ACE) Inhibitors Picture
Figure 4. Pirfenidone Picture
Figure 5. Renin Inhibitors Picture
Figure 6. Angiotensin II Receptor Blockers (ARBs) Picture
Figure 7. Vasopeptidase Inhibitors Picture
Figure 8. Kidney (Renal) Fibrosis Sales Market Share by Application in 2018
Figure 9. Research Center Picture
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Global Kidney (Renal) Fibrosis Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Kidney (Renal) Fibrosis Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Kidney (Renal) Fibrosis Sales Market Share by Manufacturer in 2019
Figure 33. Global Kidney (Renal) Fibrosis Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Kidney (Renal) Fibrosis Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Kidney (Renal) Fibrosis Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 38. Global Kidney (Renal) Fibrosis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Kidney (Renal) Fibrosis Revenue Market Share by Regions (2015-2020)
Figure 40. Global Kidney (Renal) Fibrosis Revenue Market Share by Regions in 2018
Figure 41. North America Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
Figure 42. Europe Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
Figure 44. South America Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020)
Figure 46. North America Kidney (Renal) Fibrosis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Kidney (Renal) Fibrosis Sales Market Share by Countries (2015-2020)
Figure 48. North America Kidney (Renal) Fibrosis Sales Market Share by Countries in 2018
Figure 49. North America Kidney (Renal) Fibrosis Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Kidney (Renal) Fibrosis Revenue Market Share by Countries in 2018
Figure 51. United States Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 52. Canada Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 53. Mexico Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 54. Europe Kidney (Renal) Fibrosis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Kidney (Renal) Fibrosis Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Kidney (Renal) Fibrosis Revenue Market Share by Countries in 2019
Figure 57. Germany Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 58. UK Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 59. France Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 60. Russia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 61. Italy Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 62. Asia-Pacific Kidney (Renal) Fibrosis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Kidney (Renal) Fibrosis Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Kidney (Renal) Fibrosis Revenue Market Share by Regions 2019
Figure 65. China Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 66. Japan Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 67. Korea Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 68. India Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 69. Southeast Asia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 70. South America Kidney (Renal) Fibrosis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Kidney (Renal) Fibrosis Sales Market Share by Countries in 2019
Figure 72. South America Kidney (Renal) Fibrosis Revenue Market Share by Countries in 2019
Figure 73. Brazil Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 74. Argentina Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 75. Middle East and Africa Kidney (Renal) Fibrosis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Kidney (Renal) Fibrosis Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Kidney (Renal) Fibrosis Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Kidney (Renal) Fibrosis Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 80. Egypt Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 81. Turkey Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 82. South Africa Kidney (Renal) Fibrosis Sales and Growth Rate (2015-2020) (MT)
Figure 83. Global Kidney (Renal) Fibrosis Sales and Growth Rate (2021-2025) (MT)
Figure 84. Global Kidney (Renal) Fibrosis Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Kidney (Renal) Fibrosis Market Forecast (2021-2025) (MT)
Figure 86. Europe Sales Kidney (Renal) Fibrosis Market Forecast (2021-2025) (MT)
Figure 87. Asia-Pacific Sales Kidney (Renal) Fibrosis Market Forecast (2021-2025) (MT)
Figure 88. South America Sales Kidney (Renal) Fibrosis Market Forecast (2021-2025) (MT)
Figure 89. Middle East & Africa Sales Kidney (Renal) Fibrosis Market Forecast (2021-2025) (MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…- 腎疾患の世界市場（～2026年） Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Considering the global scenario of the market, North America is believed to be the largest market f…
- 慢性腎臓病（CKD）の世界市場（～2026年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Kidney Disease (CKD) Scope and Market Size Chroni…
- 体外血液治療の世界市場（～2026年） The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood. The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases. Market Analysis and Insights: Global Extracorporeal Blood Treatment Market The glo…
- 特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…